Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q2 EPS of ($0.40), $0.01 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.